Risk Stratification in Arrhythmogenic Right Ventricular Cardiomyopathy.

Arrhythm Electrophysiol Rev · 2021 · PMC8076971 · PMID 33936740

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

in 2005 suggested that LV involvement showed a trend towards predicting appropriate ICD therapy.[ 41 ] More recent studies have provided stronger evidence that LV involvement and dysfunction increase VA risk.[ 29 , 42 – 44 ] Given the progressive nature of ARVC, we suggest that the degree of myocardial involvement is reassessed periodically to re-stratify a patient’s risk.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.